Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

BMS secures FDA accelerated approval for Zenbexus in multiple myeloma

In combination with ZDd, Zenbexus received the agency’s decision following results from the Phase III EXCALIBER-RRMM trial.

Latest news

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.

Xanadu and University of Alberta to develop quantum algorithms for cancer

The project combines Xanadu’s algorithms team and the University of Alberta chemistry professor Alex Brown.

United global response to US childhood vaccine overhaul 

Recommended changes to the US immunisation schedule by President Trump have been met with widespread retaliation.

Akeso secures China NMPA authorisation for ivonescimab combo

The authorisation is based on data from the HARMONi-6 multi-centre Phase III study that was conducted in China.

Repligen’s deal for BioLife Solutions indicates shift to manufacturing integration   

Repligen’s $1.5bn purchase of BioLife Solutions adds CryoStor biopreservation to its bioprocessing portfolio, underscoring pharma’s shift toward integrated cell and gene therapy supply chains.

Eli Lilly cracks down on illicit weight loss drug trade with US lawsuits

Lilly is suing several US companies that are allegedly selling illegal versions of its weight loss candidate, retatrutide.